Sort   by:  
 Page size 
We collected longitudinally human NK cells from patients after alloSCT (at days +90, +120, +180), to identify any potential functional NK cell defects on a protein level. We have focused our analysis on whole proteome patterns by analyzing patient NK cells stimulated with A. fumigatus or left unstim...
ORGANISM(S): Neosartorya fumigata (Aspergillus fumigatus) Homo sapiens (Human) 
2026-04-30 | PXD068702 | Pride
TCR repertoire of CMV-specific CTLs after alloSCT
Gene expression profile at single cell level of bone marrow (BM) T cells and hematopoietic stem and progenitor cells (HSPCs) of acute myeloid leukemia patients post allogeneic stem cell transplantation (alloSCT) of patients in complete remission (CR) and relapse (REL).
ORGANISM(S): Homo sapiens 
2024-01-11 | GSE216187 | GEO
scRNAseq of bone marrow (BM) T cells and hematopoietic stem and progenitor cells (HSPCs) of acute myeloid leukemia patients post allogeneic stem cell transplantation (alloSCT).
Engraftment and differentiation of donor hematopoietic stem cells is decisive for the clinical success of allogeneic stem cell transplantation (alloSCT) and depends on the recipient’s bone marrow (BM) niche. Presumably, a damaged niche contributes to poor graft function post-alloSCT, but the underly...
ORGANISM(S): Homo sapiens 
2023-05-01 | GSE203246 | GEO
BACKGROUND - IL-6 mediates graft-versus-host disease (GVHD) in experimental allogeneic stem cell transplantation (alloSCT) and is an attractive therapeutic target. METHODS - A registered phase I/II study (ACTRN12612000726853) of IL-6 receptor (IL-6R) neutralizing antibody administration on day -1 to...
ORGANISM(S): Homo sapiens 
Despite available diagnostic tests and recent advances, diagnosis of pulmonary invasive aspergillosis (IPA) remains challenging. By undertaking a longitudinal case-control study, we explored the possibility to identify novel non-invasive human biomarkers candidates for IPA in patients post allogenei...
ORGANISM(S): Homo sapiens 
2022-03-02 | GSE174825 | GEO
BACKGROUND - IL-6 mediates graft-versus-host disease (GVHD) in experimental allogeneic stem cell transplantation (alloSCT) and is an attractive therapeutic target. METHODS - A registered phase I/II study (ACTRN12612000726853) of IL-6 receptor (IL-6R) neutralizing antibody administration on day -1 to...
ORGANISM(S): Homo sapiens 
2014-09-09 | GSE61201 | GEO
Sort   by:  
 Page size